IDEAYA Biosciences宣布根据纳斯达克上市规则5635（c）授予诱导金-动脉橙

IDEAYA Biosciences宣布根据纳斯达克上市规则5635（c）授予诱导金

2024-05-31 BioSpace 等20家媒体报道公司动态





2024年5月30日，精准医学肿瘤学公司IDEAYA Biosciences宣布，根据2023年就业诱导奖励计划，向两名新员工授予不合格股票期权，以购买49000股。该计划专门向新员工提供股权奖励，作为加入IDEAYA的诱因，符合纳斯达克规则。这些期权的行使价格为35.79美元，期限为10年，根据员工的持续服务情况，可在四年内授予。（摘要由动脉网AI生成）

关联公司

 IDEAYA Biosciences

2024-05-31 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - May 31, 2024

BioSpace
2024-06-03 Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024

BioSpace
2024-06-03 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 3, 2024

BioSpace
2024-06-03 Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BioSpace
2024-06-03 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 03, 2024

BioSpace
2024-06-03 Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - June 03, 2024

BioSpace
2024-06-03 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 03, 2024

BioSpace
2024-06-03 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - June 03, 2024

BioSpace
2024-06-03 Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 03, 2024

BioSpace
2024-06-03 Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - June 03, 2024

BioSpace
2024-06-04 Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis
2024-06-04 Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-04 Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024

BioSpace
2024-06-05 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 5, 2024

BioSpace
2024-06-06 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 06, 2024

BioSpace